Amy C. Peterson, CMO, Immuno-oncology at BeiGene, Ltd. (BGNE), sold 12,800 shares at $122.55 ($1.5M) on 2018-11-09, disclosed to the SEC on 2018-11-13.
Open-market sale of $1.5M BGNE by CMO, Immuno-oncology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $118.64 | 4,031 | $478K | 31.0% |
| 2 | $119.27 | 1,725 | $206K | 13.4% |
| 3 | $120.63 | 2,100 | $253K | 16.4% |
| 4 | $121.71 | 2,898 | $353K | 22.9% |
| 5 | $122.55 | 2,046 | $251K | 16.3% |
| Total | $120.37 avg | 12,800 |
| $1.5M |
| 100% |
| Filing → |
| CTMX | SELL | 2022-07-21 | $11K | — | Filing → |
| BGNE | SELL | 2018-12-19 | $4.5M | — | Filing → |
| BGNE | SELL | 2018-12-19 | $1.4M | — | Filing → |